IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial
暂无分享,去创建一个
Huji Xu | Ling Zhou | Ting Li | Jian Wu | Guixiu Shi | D. He | Y. Xiong | Xiaomei Li | X. Wu | L. Bi | Zhijun Li | Lijun Wu | W. Xiao | Xu Liu | Juan Li | Yi Zheng | Z. Shuai | Zhengyu Xiao | Shu-Han Lu | Hui Zhou | Hongbin Li | Yongfu Wang | Shirui Zheng | Q. Xing | Xinjiang Wu | L. Luo | W. Tan | Xiaoxia Li | L. Qian | Xiong Wang | Yanqi Wang